Cleveland BioLabs (CBLI) Recieves FDA Minutes and Advice Letter for Entolimod
Tweet Send to a Friend
Cleveland BioLabs, Inc. (Nasdaq: CBLI) today announced the receipt of the End-of-Phase II meeting minutes (the "Minutes") and an Advice ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
